Evaluation of Adherence, Persistence and Efficacy of Treatment With PCSK9 Inhibitors in Italy

Sponsor
Federico II University
Study ID
NCT05430828
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

Evaluation of adherence, persistence and efficacy of treatment with PCSK9 inhibitors in a real-life Italian population.

Key Dates

First listed
Jun 24, 2022
Start date
Mar 7, 2020
Status verified
Jan 2026
Primary completion
Jan 30, 2022
Completion
Mar 31, 2030

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: Group 1
    Subjects with hyperlipidaemia under PCSK9 inhibitors treatment (Repatha/Praulent).

Primary Outcome Measure

Description of adherence of treatment with PCSK9 inhibitors in a real-life Italian population. [ Time Frame: every 6 months ]

Central Contacts

Related Studies